Showing results (961-970 of 2,445) with videos related to
Sort By:
Pageof 245
Clinical and Translational Science|February 28, 2021
Estimating peptide half-life in serum from tunable, sequence-related physicochemical propertiesMarco Cavaco, Javier Valle, Isabel Flores, et al.Clinical and Translational Science|March 2, 2021
Analysis of GABRG2 C588T polymorphism in genetic epilepsy and evaluation of GABRG2 in drug treatmentShitao Wang, Xianjun Zhang, Liang Zhou, et al.Clinical and Translational Science|March 2, 2021
Population pharmacokinetic analysis of apomorphine sublingual film or subcutaneous apomorphine in healthy subjects and patients with Parkinson's diseaseFelix Agbo, Ryan L Crass, Yu-Yuan Chiu, et al.Clinical and Translational Science|March 20, 2021
Exploratory window-of-opportunity trial to investigate the tumor pharmacokinetics/pharmacodynamics of the IAP antagonist Debio 1143 in patients with head and neck cancerCarlos Gomez-Roca, Caroline Even, Christophe Le Tourneau, et al.Clinical and Translational Science|March 20, 2021
A retrospective analysis of actionable pharmacogenetic/genomic biomarker language in FDA labelsShinji YamazakiClinical and Translational Science|March 20, 2021
A metabolomic analysis of thiol response for standard and modified N-acetyl cysteine treatment regimens in patients with acetaminophen overdoseJames W Dear, Mei Li Ng, D Nicholas Bateman, et al.Clinical and Translational Science|January 11, 2014
People United to Sustain Health (PUSH): a community-based participatory research studyBetty M Kennedy, Peter T Katzmarzyk, William D Johnson, et al.Clinical and Translational Science|May 20, 2014
Engaging the underserved: a process model to mobilize rural community health coalitions as partners in translational researchMelinda M Davis, Susan Aromaa, Paul B McGinnis, et al.Clinical and Translational Science|February 5, 2022
Leveraging large observational studies to discover genetic determinants of drug concentrations: A proof-of-concept studyMaxime Meloche, Grégoire Leclair, Martin Jutras, et al.Clinical and Translational Science|February 9, 2022
A randomized, controlled, feasibility study of RD-X19 in subjects with mild-to-moderate COVID-19 in the outpatient settingNathan Stasko, Adam S Cockrell, Jacob F Kocher, et al.Pageof 245